Related Experiment Video

Updated: Jun 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

MicroRNA-183 regulates Ezrin expression in lung cancer cells

Guofu Wang1, Weimin Mao, Shu Zheng

  • 1The 2nd Affiliated Hospital, School of Medicine, College of Life Sciences, Zhejiang University, Hangzhou, China.

FEBS Letters
|October 9, 2008
PubMed

Insights

MicroRNA-183 (miR-183) acts as a metastasis inhibitor in lung cancer. Increasing miR-183 levels reduces cancer cell migration and invasion by targeting Ezrin, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer remains the leading cause of cancer-related mortality worldwide.
  • The molecular mechanisms underlying lung cancer metastasis and relapse are not fully understood.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in regulating tumor progression and metastasis.

Purpose of the Study:

  • To investigate the role of microRNA-183 (miR-183) in lung cancer metastasis.
  • To identify potential targets of miR-183 involved in cancer cell migration and invasion.

Main Methods:

  • Correlation analysis of miR-183 expression levels with lung cancer cell metastatic potential.
  • In vitro assays to assess the effect of miR-183 overexpression on cell migration and invasion.
  • Target validation to identify direct molecular targets of miR-183.

Main Results:

  • miR-183 expression was inversely correlated with the metastatic potential of lung cancer cells.
  • Overexpression of miR-183 significantly inhibited lung cancer cell migration and invasion.
  • Ezrin (VIL2-coding protein) was identified as a direct target of miR-183.
  • miR-183 was found to regulate other genes implicated in cell migration and invasion.

Conclusions:

  • miR-183 functions as a novel metastasis suppressor in lung cancer.
  • The miR-183/Ezrin axis plays a critical role in controlling lung cancer cell motility.
  • These findings elucidate a new regulatory mechanism for lung cancer metastasis and suggest miR-183 as a potential therapeutic target.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...